Design, Synthesis, and Pharmacological Evaluation of Second-Generation Soluble Adenylyl Cyclase (sAC, ADCY10) Inhibitors with Slow Dissociation Rates
作者:Michael Miller、Thomas Rossetti、Jacob Ferreira、Lubna Ghanem、Melanie Balbach、Navpreet Kaur、Lonny R. Levin、Jochen Buck、Maria Kehr、Sandrine Coquille、Joop van den Heuvel、Clemens Steegborn、Makoto Fushimi、Efrat Finkin-Groner、Robert W. Myers、Stacia Kargman、Nigel J. Liverton、David J. Huggins、Peter T. Meinke
DOI:10.1021/acs.jmedchem.2c01133
日期:2022.11.24
two processes central to oocyte fertilization. Pharmacologic evaluation of existing sAC inhibitors for utility as on-demand, nonhormonal male contraceptives suggested that both high intrinsic potency, fast on and slow dissociation rates are essential design elements for successful male contraceptive applications. During the course of the medicinal chemistry campaign described here, we identified sAC inhibitors
可溶性腺苷酸环化酶(sAC:ADCY10)是一种参与细胞内信号传导的酶。 sAC 的抑制在许多领域具有潜在的治疗用途。例如,sAC 对于男性成功生育至关重要:sAC 激活是精子活力和进行顶体反应的能力所必需的,这两个过程是卵母细胞受精的核心过程。对现有 sAC 抑制剂作为按需非激素男性避孕药的药理学评估表明,高内在效力、快速作用和缓慢解离速率是成功男性避孕药应用的基本设计要素。在此描述的药物化学活动过程中,我们确定了满足这些标准并适合多种 sAC 药理学的体内评估的 sAC 抑制剂。